Skip to main content
. Author manuscript; available in PMC: 2013 Feb 7.
Published in final edited form as: Breast Cancer Res Treat. 2012 Jun 16;135(1):115–124. doi: 10.1007/s10549-012-2125-2

Fig. 3.

Fig. 3

Box-and-whisker plots showing the changes in nuclear nano-morphology markers from all 6 categories with a broad range of breast pathology entities: a average nuclear OPD ((〈OPD〉)p) and b intra-nuclear standard deviation of OPD ((σOPD)p). For each patient, we used the mean value of 〈OPD〉 and σOPD by averaging ~40–60 cell nuclei. If P value is 0.1 or larger, “NS” is used